SCOPUS 정보 검색 플랫폼

Volumn 92, Issue 4, 2001, Pages 474-479

C-erbB-2 expression in small-cell lung cancer is associated with poor prognosis

(9) Micke, Patrick a Hengstler, Jan Georg b Ros, Er b Bittinger, Fernando a Metz, Tsegay a Gebhard, Susanne a Beeh, Kai Michael a Oesch, Franz a Buhl, Roland a

a UNIVERSITY MEDICAL CENTER MAINZ (Germany)

b JOHANNES GUTENBERG UNIVERSITY (Germany)

Author keywords

C erbB 2; HER 2 neu; Prognosis; Small cell lung cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; TYROSINE KINASE RECEPTOR; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE C ERB; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS;

AGE FACTORS; AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, SMALL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ERBB-2; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035874049 PISSN: 00207136 EISSN: None Source Type: Journal
DOI: 10.1002/ijc.1229 Document Type: Article

Times cited : (76)

References (34)

1
- 0030876445
- Small cell lung cancer: State-of-the-art therapy in 1996
- (1997) Chest , vol.12
- Elias, A.D.¹

2
- 0031915133
- Small-cell lung cancer: A perspective on the past and a preview of the future
- (1998) Oncology (Huntingt) , vol.12 , pp. 44-50
- Comis, R.L.¹ Friedland, D.M.² Good, B.C.³

3
- 0032840016
- Second-line chemotherapy and its evaluation in small cell lung cancer
- (1999) Cancer Treat Rev , vol.25 , pp. 199-206
- Huisman, C.¹ Postmus, P.E.² Giaccone, G.³ Smit, E.F.⁴

4
- 0025807175
- Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience
- (1991) Chest , vol.99 , pp. 1425-1432
- Albain, K.S.¹ Crowley, J.J.² Livingston, R.B.³

5
- 0001921051
- Prognostic factors: From clinical parameters to new biological markers
- Van Houtte P, Klastersky J, Rocmans JP. Berlin: Springer
- (1999) Progress and perspectives in the treatment of lung cancer , pp. 1-21
- Sørensen, J.B.¹ Østerlind, K.²

6
- 0022399581
- Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
- (1985) Science , vol.6 , pp. 1132-1139
- Coussens, L.¹ Yang-Feng, T.L.² Liao, Y.C.³ Chen, E.⁴ Gray, A.⁵ McGrath, J.⁶

7
- 0028170817
- Receptor protein-tyrosine kinases and their signal transduction pathways
- (1994) Annu Rev Cell Biol , vol.10 , pp. 251-337
- Van der Geer, P.¹ Hunter, T.² Lindberg, R.A.³

8
- 0032852374
- ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells
- (1999) Int J Cancer , vol.12 , pp. 564
- Fernandes, A.¹ Hamburger, A.W.² Gerwin, B.I.³

9
- 0032794761
- Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer
- (1999) Int J Cancer , vol.84 , pp. 421-425
- Morote, J.¹ De Torres, I.² Caceres, C.³ Vallejo, C.⁴ Schwartz S., Jr.⁵ Reventos, J.⁶

10
- 0033168055
- Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer
- (1999) Cancer Res , vol.59 , pp. 3206-3214
- Hengstler, J.G.¹ Lange, J.² Kett, A.³ Dornhofer, N.⁴ Meinert, R.⁵ Arand, M.⁶

11
- 0023192376
- Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody
- (1987) J Natl Cancer Inst , vol.79 , pp. 403-407
- Sobol, R.E.¹ Astarita, R.W.² Hofeditz, C.³ Masui, H.⁴ Fairshter, R.⁵ Royston, I.⁶

12
- 0026549424
- Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer
- (1992) Mol Carcinog , vol.5 , pp. 213-218
- Shi, D.¹ He, G.² Cao, S.³ Pan, W.⁴ Zhang, H.Z.⁵ Yu, D.⁶

13
- 0025190758
- Expression of the neu gene-encoded protein (p185neu) in human non-small cell carcinomas of the lung
- (1990) Cancer Res , vol.50 , pp. 421-425
- Weiner, D.B.¹ Nordberg, J.² Robinson, R.³ Nowell, P.C.⁴ Gazdar, A.⁵ Greene, M.I.⁶

14
- 0029017845
- Localized adenocarcinoma of the lung: Oncogene expression of erbB-2 and p53 in 150 patients
- (1995) Clin Cancer Res , vol.1 , pp. 659-664
- Harpole D.H., Jr.¹ Marks, J.R.² Richars, W.G.³ Herndon II, J.E.⁴ Sugarbaker, D.J.⁵

15
- 0025708183
- p185neu expression in human lung adenocarcinomas predicts shortened survival
- (1990) Cancer Res , vol.50 , pp. 5184-5187
- Kern, J.A.¹ Schwartz, D.A.² Nordberg, J.E.³ Weiner, D.B.⁴ Greene, M.I.⁵ Torney, L.⁶

16
- 0025952816
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
- (1991) Eur J Cancer , vol.27 , pp. 1372-1375
- Tateishi, M.¹ Ishida, T.² Mitsudomi, T.³ Kaneko, S.⁴ Sugimachi, K.⁵

17
- 0030005871
- Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer
- (1996) Ann Thorac Surg , vol.61 , pp. 1470-1476
- Harpole D.H., Jr.¹ Richards, W.G.² Herndon II, J.E.³ Sugarbaker, D.J.⁴

18
- 0033015810
- Study of prognostic predictors for non-small cell lung cancer
- (1999) Lung Cancer , vol.23 , pp. 143-152
- Fu, X.L.¹ Zhu, X.Z.² Shi, D.R.³ Xiu, L.Z.⁴ Wang, L.J.⁵ Zhao, S.⁶

19
- 0030054716
- Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: An immunohistochemical study on cryosections
- (1996) Br J Cancer , vol.74 , pp. 86-91
- Pfeiffer, P.¹ Clausen, P.P.² Andersen, K.³ Rose, C.⁴

20
- 0002617112
- Epidermal growth factor receptors and c-erbB-2 in human lung cancer
- Pass HI, Mitchell JB, Johnson DH, Turrisi AT. Philadelphia: Lippincott
- (1995) Lung cancer. Principles and practise , pp. 107-121
- Arteaga, C.L.¹

21
- 0029902993
- Immunohistochemical markers of prolonged survival in small cell carcinoma of the lung. An immunohistochemical study
- (1996) Arch Pathol Lab Med , vol.120 , pp. 465-472
- Sloman, A.¹ D'amico, F.² Yousem, S.A.³

22
- 0003496954
- New York: Wiley-Liss, Inc.
- (1980) The statistical analysis of failure data
- Kalbfleisch, J.D.¹ Prentice, R.C.²

23
- 0024421662
- Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer
- (1989) Cancer Res , vol.49 , pp. 4968-4971
- Schneider, P.M.¹ Hung, M.C.² Chiocca, S.M.³ Manning, J.⁴ Zhao, X.Y.⁵ Fang, K.⁶

24
- 0024310196
- Amplification of protooncogenes in surgical specimens of human lung carcinomas
- (1989) Cancer Res , vol.49 , pp. 6474-6479
- Shiraishi, M.¹ Noguchi, M.² Shimosato, Y.³ Sekiya, T.⁴

25
- 0031034106
- HER-2/neu signal transduction in human breast and ovarian cancer
- (1997) Stem Cells , vol.15 , pp. 1-8
- Reese, D.M.¹ Slamon, D.J.²

26
- 0030828285
- Mdm-2 mRNA expression is associated with survival in ovarian cancer
- (1997) Int J Cancer , vol.74 , pp. 438-442
- Tanner, B.¹ Hengstler, J.G.² Laubscher, S.³ Meinert, R.⁴ Oesch, F.⁵ Weikel, W.⁶ Knapstein, P.G.⁷ Becker, R.⁸

27
- 0032766511
- Activity of O(6)-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer
- (1999) Int J Cancer , vol.84 , pp. 388-395
- Hengstler, J.G.¹ Tanner, B.² Moller, L.³ Meinert, R.⁴ Kaina, B.⁵

28
- 0031963398
- Overexpression of the oncogene c-erbB-2 (HER-2/neu) and response to chemotherapy in patients with ovarian cancer
- (1998) Int J Gynecol Pathol , vol.17 , pp. 61-65
- Meden, H.¹ Marx, D.² Roegglen, T.³ Schauer, A.⁴ Kuhn, W.⁵

29
- 0033009904
- C-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy
- (1999) Int J Cancer , vol.84 , pp. 129-134
- Vargas-Roig, L.M.¹ Gago, F.E.² Tello, O.³ Martin De Civetta, M.T.⁴ Ciocca, D.R.⁵

30
- 0000405942
- Addition of Herceptin of first-line chemotherapy for HER2 overexpressing metastatic breast cancer (HER2+/MBC) markedly increases anticancer activity; a randomized multinational controlled phase III trial
- (1998) Proc Am So Clin Oncol , vol.17
- Slamon, D.¹ Leyland-Jones, B.² Shak, S.³

31
- 0000007793
- Phase II Eastern Cooperative Oncology Group (ECOG) pilot study of paclitaxel, carboplatin and trastzumab in HER/neu positive advanced NSCLC: Preliminary analysis
- (2000) Lung Cancer , vol.29 , Issue.S2 , pp. 142
- Langer, C.¹ Adak, S.² Thor, A.³ Johnson, D.⁴

32
- 17444448391
- The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis
- (2000) Nat Med , vol.6 , pp. 189-195
- Xing, X.¹ Wang, S.C.² Xia, W.³ Zou, Y.⁴ Shao, R.⁵ Kwong, K.Y.⁶

33
- 0032184864
- HER-2 breast assay, linked to Herceptin, wins FDA's okay
- (1998) CAP Today , vol.12 , pp. 14-16
- Graziano, C.¹

34
- 0015861452
- Keynote address on biostatistics and data retrieval
- (1973) Cancer Chemother Rep , vol.4 , pp. 31-42
- Zelen, M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.